PubRank

Carlo Buzio

Author PubWeight™ 53.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Retroperitoneal fibrosis. Lancet 2006 4.57
2 Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet 2011 3.19
3 Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005 2.50
4 Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med 2003 1.94
5 Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: insights into mechanisms of myocardial cell death. Hum Pathol 2004 1.84
6 HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. Arthritis Rheum 2007 1.76
7 Outcome and prognostic factors during the course of primary small-vessel vasculitides. J Rheumatol 2006 1.69
8 Asbestos and smoking as risk factors for idiopathic retroperitoneal fibrosis: a case-control study. Ann Intern Med 2014 1.50
9 Renal involvement in Churg-Strauss syndrome. Am J Kidney Dis 2006 1.43
10 Positron emission tomography (PET): evaluation of chronic periaortitis. Arthritis Rheum 2005 1.29
11 Chronic periaortitis: a spectrum of diseases. Curr Opin Rheumatol 2005 1.28
12 Autoimmune aspects of chronic periaortitis. Autoimmun Rev 2006 1.24
13 Peripheral neuropathy in Wegener's granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis. J Neurol Neurosurg Psychiatry 2007 1.13
14 Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature. Nephrol Dial Transplant 2013 1.11
15 (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis. Arthritis Rheum 2005 1.05
16 Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum 2006 0.97
17 Ear, nose and throat manifestations of Churg-Strauss syndrome. Acta Otolaryngol 2006 0.96
18 PTPN22 R620W polymorphism in the ANCA-associated vasculitides. Rheumatology (Oxford) 2012 0.95
19 Nasal polyposis in Churg-Strauss syndrome. Laryngoscope 2008 0.89
20 Retroperitoneal fibrosis: evolving concepts. Rheum Dis Clin North Am 2007 0.88
21 Rituximab therapy for chronic periaortitis. Ann Rheum Dis 2012 0.86
22 Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): a phase III, randomized, multicentre trial of the Italian Oncology Group for Clinical Research (GOIRC). J Immunother 2014 0.86
23 Respiratory system involvement in ANCA-associated systemic vasculitides. Sarcoidosis Vasc Diffuse Lung Dis 2005 0.84
24 Subcutaneous panniculitis-like T-cell lymphoma with overlapping clinicopathologic features of lupus erythematosus: coexistence of 2 entities? Am J Dermatopathol 2009 0.84
25 Prognostic significance of albuminuria in patients with renal cell cancer. J Urol 2003 0.84
26 Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis. Ann Rheum Dis 2013 0.83
27 Eotaxin/CCL11 in idiopathic retroperitoneal fibrosis. Nephrol Dial Transplant 2012 0.83
28 Churg-Strauss syndrome. Kidney Int 2009 0.82
29 Candida sake as the causative agent of spondylodiscitis in a hemodialysis patient. Spine J 2011 0.82
30 Immunohaematological and apheretic aspects of the first kidney transplant from a living, ABO-incompatible donor carried out in Italy. Blood Transfus 2010 0.82
31 Early proinflammatory activation of renal tubular cells by normal and pathologic IgG. Nephron Exp Nephrol 2005 0.81
32 HCV-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosuppressive therapies. Acta Biomed 2007 0.80
33 Orofacial granulomatosis treated with low-level laser therapy: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol 2012 0.80
34 Tuberculosis as a trigger of retroperitoneal fibrosis. Clin Infect Dis 2005 0.79
35 Antifibroblast antibodies from systemic sclerosis patients are internalized by fibroblasts via a caveolin-linked pathway. Arthritis Rheum 2002 0.79
36 Large bowel obstruction heralding Churg-Strauss syndrome. Am J Gastroenterol 2004 0.79
37 Pericarditis heralding Erdheim-Chester disease. Circulation 2008 0.79
38 CC chemokine receptor 5 polymorphism in chronic periaortitis. Rheumatology (Oxford) 2011 0.79
39 TLR-4 and VEGF polymorphisms in chronic periaortitis. PLoS One 2013 0.78
40 Calciphylaxis: evolving concepts. Intern Emerg Med 2006 0.77
41 Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies. Ann Ital Med Int 2005 0.77
42 Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-alpha for metastatic renal cell cancer. Cancer Immunol Immunother 2009 0.76
43 Successful treatment of severe/active cryoglobulinaemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection by means of the sequential administration of immunosuppressive and antiviral agents. Nephrol Dial Transplant 2006 0.76
44 Chronically administered immunotherapy with low-dose IL-2 and IFN-alpha in metastatic renal cell carcinoma: a feasible option for patients with a good prognostic profile. Oncology 2008 0.76
45 Peri-renal collateral circles. Urology 2009 0.76
46 [Churg-Strauss syndrome]. Recenti Prog Med 2003 0.76
47 Low doses of subcutaneous interleukin-2 plus interferon-alpha do not induce thyroid function alterations in advanced renal cell carcinoma patients. Oncol Rep 2004 0.76
48 New aspects of membranoproliferative glomerulonephritis. N Engl J Med 2012 0.76
49 Incidence and prevalence of cancer in kidney transplantation waiting list patients: an Italian experience. Int J Artif Organs 2013 0.75
50 Tamoxifen therapy for retroperitoneal fibrosis. Ann Intern Med 2006 0.75
51 Diagnosis of Churg-Strauss syndrome: eotaxin-3 makes it easier. Rheumatology (Oxford) 2011 0.75
52 Simultaneous kidney-pancreas transplantation: the Parma Center experience. Acta Biomed 2007 0.75
53 "Late" regressions of metastases from renal cancer after a period of disease progression continuing the same intermittent low dose immunotherapy regimen. Acta Biomed 2004 0.75
54 Changes in lymphocyte count induced by repeated cycles with low-dose interleukin-2 and interferon-α in 146 patients with renal cell carcinoma. Tumori 2012 0.75
55 Impact of posttransplant lymphoproliferative disorders on kidney graft survival: a pilot study. Transplantation 2014 0.75
56 Role of chemotherapy with gemcitabine plus 5-fluorouracil and chemoimmunotherapy in metastatic renal cell cancer (mRCC). J Immunother 2007 0.75